Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernst R Berndt

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Pharmacoeconomics|January 22, 2005
Changes in the costs of treating mental health disorders: an overview of recent research findingsErnst R Berndt
The New England Journal of Medicine|January 28, 2005
To inform or persuade? Direct-to-consumer advertising of prescription drugsErnst R Berndt
Health Affairs (Project Hope)|March 9, 2004
Unique issues raised by drug benefit designErnst R Berndt
The Journal of Economic Perspectives : a Journal of the American Economic Association|June 8, 2004
Pharmaceuticals in U.S. health care: determinants of quantity and priceErnst R Berndt
Marketing Health Services|March 30, 2005
Being directJulie M Donohue, Ernst R Berndt
Drug Discovery Today|November 7, 2015
The clinical benefits, ethics, and economics of stratified medicine and companion diagnosticsMark R Trusheim, Ernst R Berndt
Psychopharmacology Bulletin|December 20, 2002
Depression treatment: a lifelong commitment?Martin B Keller, Ernst R Berndt
International Journal of the Economics of Business|October 12, 2020
FOUR FACTS CONCERNING COMPETITION IN U.S. GENERIC PRESCRIPTION DRUG MARKETSRena M Conti, Ernst R Berndt
Health Affairs (Project Hope)|May 12, 2005
Vaccine advance-purchase agreements for low-income countries: practical issuesErnst R Berndt, John A Hurvitz
Personalized Medicine|May 20, 2018
Economic challenges and possible policy actions to advance stratified medicineMark R Trusheim, Ernst R Berndt
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Pharmacoeconomics|January 22, 2005
Changes in the costs of treating mental health disorders: an overview of recent research findingsErnst R Berndt
The New England Journal of Medicine|January 28, 2005
To inform or persuade? Direct-to-consumer advertising of prescription drugsErnst R Berndt
Health Affairs (Project Hope)|March 9, 2004
Unique issues raised by drug benefit designErnst R Berndt
The Journal of Economic Perspectives : a Journal of the American Economic Association|June 8, 2004
Pharmaceuticals in U.S. health care: determinants of quantity and priceErnst R Berndt
Marketing Health Services|March 30, 2005
Being directJulie M Donohue, Ernst R Berndt
Drug Discovery Today|November 7, 2015
The clinical benefits, ethics, and economics of stratified medicine and companion diagnosticsMark R Trusheim, Ernst R Berndt
Psychopharmacology Bulletin|December 20, 2002
Depression treatment: a lifelong commitment?Martin B Keller, Ernst R Berndt
International Journal of the Economics of Business|October 12, 2020
FOUR FACTS CONCERNING COMPETITION IN U.S. GENERIC PRESCRIPTION DRUG MARKETSRena M Conti, Ernst R Berndt
Health Affairs (Project Hope)|May 12, 2005
Vaccine advance-purchase agreements for low-income countries: practical issuesErnst R Berndt, John A Hurvitz
Personalized Medicine|May 20, 2018
Economic challenges and possible policy actions to advance stratified medicineMark R Trusheim, Ernst R Berndt
Pageof 6